Methods and systems for stiffening of tissue for improved processing
Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions including an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue can be used in the creation of wound treatment devices.
1. A method of producing a wound treatment device, comprising:
selecting a tissue;
contacting the tissue with a solution comprising an acid or a base at a concentration selected to produce a level of stiffness in one or more components in the tissue sufficient to tolerate machining and wherein the solution does not cause substantial irreversible denaturation of one or more components in the tissue; and
machining the stiffened tissue to produce a desired size and shape.
2. The method of claim 1 , wherein the tissue is dermal tissue.
3. The method of claim 1 , wherein the tissue is at least one of fascia, pericardial tissue, dura, umbilical cord tissue, cartilage, tendon, reticulate, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, and small-intestine submucosa.
4. The method of claim 1 , wherein the one or more components include collagen fibers.
5. The method of claim 1 , wherein the solution comprises acetic acid at a concentration of 0.1 M or less.
6. The method of claim 1 , wherein the solution has a pH value between 2 and 3.5.
7. The method of claim 1 , wherein the step of machining the stiffened tissue comprises machining the stiffened tissue to form an elongated shape.
8. The method of claim 7 , wherein the elongated shape is cylindrical and has a length of at least 1 centimeter.
9. The method of claim 7 , wherein the elongated shape is cylindrical and has a length of at least 3 centimeters.
10. The method of claim 7 , wherein the elongated shape is cylindrical and has a length of at least 5 centimeters.
11. The method of claim 7 , wherein the elongated shape is cylindrical and has a diameter in a range of 1 to 5 millimeters.
12. The method of claim 1 , further comprising performing a decellularization process on the tissue.
13. The method of claim 12 , wherein the decellularization process is performed prior to contacting the tissue with the solution to stiffen the tissue.
14. The method of claim 12 , wherein the decellularization process is performed after contacting the tissue with the solution to stiffen the tissue and machining the tissue.
15. The method of claim 1 , further comprising treating the tissue with an enzyme.
16. The method of claim 15 , wherein the enzyme comprises a subtilisin-like serine protease.
17. The method of claim 15 , wherein the enzyme comprises at least one of bromelain, papain, ficin, actinidin, a serine endopeptidase, trypsin, or combinations thereof.
18. The method of claim 15 , wherein the enzyme is contacted with the tissue under conditions that result in a tissue having an improved biologic response when implanted in vivo.
19. The method of claim 18 , wherein the improved biologic response comprises reduced inflammation as compared to a tissue not treated with the enzyme.
20. The method of claim 18 , wherein the improved biologic response comprises improved cellular ingrowth.